Article: Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleSmad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling
AuthorsHuang, XR3
Chung, ACK3
Yang, F2
Yue, W2
Deng, C1
Lau, CP2
Tse, HF2
Lan, HY3
KeywordsAngiotensin II
Cardiac remodeling
Hypertension
Smad3
TGF-β
Issue Date2010
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://hyper.ahajournals.org/
CitationHypertension, 2010, v. 55 n. 5, p. 1165-1171 [How to Cite?]
DOI: http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.147611
AbstractAlthough Smad3 is a key mediator of fibrosis, the functional role of Smad3 in hypertensive cardiovascular disease remains unclear. The present study tested the hypothesis that angiotensin II may activate the transforming growth factor-β/Smad3 pathway to mediate hypertensive cardiac remodeling in Smad3 knockout (KO) and wild-type mice by subcutaneous angiotensin II infusion and in the primary culture of Smad3 KO cardiac fibroblasts. Fourteen days after angiotensin II infusion, both Smad3 KO and wild-type mice developed equal levels of high blood pressure. However, hypertensive cardiac fibrosis and inflammation were developed in Smad3 wild-type but not in Smad3 KO mice. This was demonstrated by the findings that mice lacking Smad3 were protected against a fall in left ventricular ejection fraction (P<0.05), an increase in left ventricular mass (P<0.05), and the development of cardiac fibrosis and inflammation, including upregulation of transforming growth factor-β1, connective tissue growth factor, collagen I/III, α-smooth muscle actin, interleukin 1β, tumor necrosis factor-α, monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and an increase in macrophage and T-cell infiltration in left ventricular tissues (all P<0.01, respectively). Additional studies in vitro also revealed that angiotensin II-induced cardiac fibrosis and inflammation were prevented in Smad3 KO cardiac fibroblasts. Inactivation of both Smad3 and nuclear factor κB/p65 signaling pathways was a key mechanism by which Smad3 KO mice were protected from angiotensin II-mediated hypertensive cardiac remodeling. In conclusion, Smad3 plays an essential role in hypertensive cardiac remodeling. Results from this study suggest that targeting Smad3 may be a novel therapeutic strategy for hypertensive cardiovascular disease. Copyright © 2010 American Heart Association. All rights reserved.
Descriptionlink_to_OA_fulltext
ISSN0194-911X
2011 Impact Factor: 6.207
2011 SCImago Journal Rankings: 0.623
DOIhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.109.147611
ISI Accession Number IDWOS:000276672500019
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorHuang, XR
dc.contributor.authorChung, ACK
dc.contributor.authorYang, F
dc.contributor.authorYue, W
dc.contributor.authorDeng, C
dc.contributor.authorLau, CP
dc.contributor.authorTse, HF
dc.contributor.authorLan, HY
dc.date.accessioned2011-07-27T01:30:12Z
dc.date.available2011-07-27T01:30:12Z
dc.date.issued2010
dc.description.abstractAlthough Smad3 is a key mediator of fibrosis, the functional role of Smad3 in hypertensive cardiovascular disease remains unclear. The present study tested the hypothesis that angiotensin II may activate the transforming growth factor-β/Smad3 pathway to mediate hypertensive cardiac remodeling in Smad3 knockout (KO) and wild-type mice by subcutaneous angiotensin II infusion and in the primary culture of Smad3 KO cardiac fibroblasts. Fourteen days after angiotensin II infusion, both Smad3 KO and wild-type mice developed equal levels of high blood pressure. However, hypertensive cardiac fibrosis and inflammation were developed in Smad3 wild-type but not in Smad3 KO mice. This was demonstrated by the findings that mice lacking Smad3 were protected against a fall in left ventricular ejection fraction (P<0.05), an increase in left ventricular mass (P<0.05), and the development of cardiac fibrosis and inflammation, including upregulation of transforming growth factor-β1, connective tissue growth factor, collagen I/III, α-smooth muscle actin, interleukin 1β, tumor necrosis factor-α, monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and an increase in macrophage and T-cell infiltration in left ventricular tissues (all P<0.01, respectively). Additional studies in vitro also revealed that angiotensin II-induced cardiac fibrosis and inflammation were prevented in Smad3 KO cardiac fibroblasts. Inactivation of both Smad3 and nuclear factor κB/p65 signaling pathways was a key mechanism by which Smad3 KO mice were protected from angiotensin II-mediated hypertensive cardiac remodeling. In conclusion, Smad3 plays an essential role in hypertensive cardiac remodeling. Results from this study suggest that targeting Smad3 may be a novel therapeutic strategy for hypertensive cardiovascular disease. Copyright © 2010 American Heart Association. All rights reserved.
dc.description.natureLink_to_subscribed_fulltext
dc.descriptionlink_to_OA_fulltext
dc.identifier.citationHypertension, 2010, v. 55 n. 5, p. 1165-1171 [How to Cite?]
DOI: http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.147611
dc.identifier.doihttp://dx.doi.org/10.1161/HYPERTENSIONAHA.109.147611
dc.identifier.epage1171
dc.identifier.hkuros187298
dc.identifier.isiWOS:000276672500019
dc.identifier.issn0194-911X
2011 Impact Factor: 6.207
2011 SCImago Journal Rankings: 0.623
dc.identifier.issue5
dc.identifier.pmid20231525
dc.identifier.scopuseid_2-s2.0-77951499390
dc.identifier.spage1165
dc.identifier.urihttp://hdl.handle.net/10722/135220
dc.identifier.volume55
dc.languageeng
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://hyper.ahajournals.org/
dc.publisher.placeUnited States
dc.relation.ispartofHypertension
dc.relation.referencesReferences in Scopus
dc.subject.meshAngiotensin II - pharmacology
dc.subject.meshHypertension - chemically induced - physiopathology
dc.subject.meshInflammation - prevention and control
dc.subject.meshSmad3 Protein - deficiency - genetics - physiology
dc.subject.meshVentricular Remodeling - drug effects - genetics - physiology
dc.subjectAngiotensin II
dc.subjectCardiac remodeling
dc.subjectHypertension
dc.subjectSmad3
dc.subjectTGF-β
dc.titleSmad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling
dc.typeArticle
Author Affiliations
  1. National Institute of Diabetes and Digestive and Kidney Diseases
  2. The University of Hong Kong
  3. Chinese University of Hong Kong